Wednesday, January 21, 2009
Japan’s Global Clinical Trials Initiations Skyrocket
While the weakening economy has forced some drug companies to cancel or delay early phase projects, at least one company has seen a growing need for its niche phase I drug development services.
CenterWatch, a global source for clinical trials information, today announced the release of its latest report, Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials. The report explores the evolution of this region that has seen its growth in the industry triple in the last five years, making it the largest area for global clinical trial initiations outside of North America and Western Europe.
Grant writing is a fundamental skill for every clinical researcher who seeks funding to conduct trials and advance medical care. Most grant reviewers have a limited amount of time to sift through a large number of proposals, so grants that are poorly written, disorganized or missing important information are likely to garner only a brief glance before being passed over. One way to guarantee your grant stands out compared to the rest is to make sure the statistical component of your study is well designed, complete, and clearly stated.
Global patient recruitment and retention firm MMG has partnered with Exco InTouch to provide mobile messaging services to its sponsor clients. According to the Rockville, Md.-based company, Exco’s mobile technology will enable sponsors to quickly identify and pre-screen potential subjects for clinical studies, as well as provide ongoing contact with patients via mobile messages, reducing the amount of input required from study organizers.
India’s booming clinical trials business is under scrutiny, following a story in a UK newspaper that set off a flurry of media and regulatory attention.